Developments in Glycopeptide Antibiotics

[Image: see text] Glycopeptide antibiotics (GPAs) are a key weapon in the fight against drug resistant bacteria, with vancomycin still a mainstream therapy against serious Gram-positive infections more than 50 years after it was first introduced. New, more potent semisynthetic derivatives that have...

Descripción completa

Detalles Bibliográficos
Autores principales: Blaskovich, Mark A. T., Hansford, Karl A., Butler, Mark S., Jia, ZhiGuang, Mark, Alan E., Cooper, Matthew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952257/
https://www.ncbi.nlm.nih.gov/pubmed/29363950
http://dx.doi.org/10.1021/acsinfecdis.7b00258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952257/
https://www.ncbi.nlm.nih.gov/pubmed/29363950
http://dx.doi.org/10.1021/acsinfecdis.7b00258

Ejemplares similares